Weekly azithromycin for 48 weeks impacts nasopharyngeal microbial prevalence and Streptococcus pneumoniae serotypes in children with HIVassociated chronic lung disease

Simple item page
dc.article.end-page14en
dc.article.start-page1en
dc.citation.doi10.1038/S41598-025-23693-6en
dc.contributor.authorP Mushunjeen
dc.contributor.authorE Sovershaevaen
dc.contributor.authorCourtney Olwagenen
dc.contributor.authorShabir Madhien
dc.contributor.authorJ Odlanden
dc.contributor.authorR Ferranden
dc.contributor.authorE et alen
dc.date.accessioned2026-02-19T11:43:05Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/48190
dc.journal.titleWeekly azithromycin for 48 weeks impacts nasopharyngeal microbial prevalence and Streptococcus pneumoniae serotypes in children with HIVassociated chronic lung diseaseen
dc.journal.volume15en
dc.titleWeekly azithromycin for 48 weeks impacts nasopharyngeal microbial prevalence and Streptococcus pneumoniae serotypes in children with HIVassociated chronic lung diseaseen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.94 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)